Clin2
NCT07518589Possibly a fitNot yet recruiting

Weight loss drug study for overweight adults

Evaluate the Safety and TolerabilityHealthy and Overweight or Obese Participants

Part of Hormones & metabolism clinical trials.

This study tests a new medication called CMS-D008 to see if it can help with weight loss in overweight or obese adults. It is an early-stage trial, so the main goals are to check safety and how the body handles the drug.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
110 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 56 years old.
  • Your body mass index (BMI) is 23 or higher, and your weight has been stable for the past 4 months.
  • You do not have diabetes (HbA1c less than 6.5% and fasting blood sugar less than 7 mmol/L).
  • You have not used weight-loss medications (like GLP-1 drugs) in the past 6 months.
  • You have not used any siRNA-based medications in the past year.
  • You are willing to use contraception if you or your partner can have children, for up to 7 months after the last dose.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07841860Not yet recruiting· Phase 1
Weight loss study for healthy and obese adults

This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.

Jinan, Shandong
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07857473Not yet recruiting· Phase 2
Weight loss study for overweight or obese adults

This study tests an investigational drug called TE-8105 to see if it is safe and effective for helping adults who are overweight or obese lose weight. It may be an option for you if you are looking for a medical approach to weight management.

Leichhardt, New South Wales
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT07809945Not yet recruiting· Phase 1
Weight loss study for people with overweight or obesity

This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.

Beijing, Beijing Municipality

Hear when a new Evaluate the Safety and Tolerability trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.